• Araújo, Joana et al. “Prevalence of Optimal Metabolic Health in American Adults: National Health and Nutrition Examination Survey 2009-2016.” Metabolic syndrome and related disorders vol. 17,1 (2019): 46-52. doi:10.1089/met.2018.0105


  • Sugita J, Yoneshiro T, Hatano T, et al. Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men. Br J Nutr. 2013 Aug;110(4):733-8. doi: 10.1017/S0007114512005715.]
  • Hattori, H., Moriyama, A., Ohno, T., Shibata, T., Iwahashi, H., & Mitsunaga, T. (2022). Molecular networking-based lipid profiling and multi-omics approaches reveal new contributions of functional vanilloids to gut microbiota and lipometabolism changes. Food chemistry. Molecular sciences, 5, 100123.


  • Roberts LD, Boström P, O'Sullivan JF, et al. b-Aminoisobutyric acid induces browning of white fat and hepatic b-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014 Jan 7;19(1):96-108. doi: 10.1016/j.cmet.2013.12.003.
  • Tanianskii DA, Jarzebska N, Birkenfeld AL, O'Sullivan JF, Rodionov RN. Beta-Aminoisobutyric Acid as a Novel Regulator of Carbohydrate and Lipid Metabolism. Nutrients. 2019 Feb 28;11(3):524. doi: 10.3390/nu11030524. PMID: 30823446; PMCID: PMC6470580.
  • Kitase, Yukiko et al. “β-aminoisobutyric Acid, l-BAIBA, Is a Muscle-Derived Osteocyte Survival Factor.” Cell reports vol. 22,6 (2018): 1531-1544. doi:10.1016/j.celrep.2018.01.041


  • Mohammad M, Al-masri IM, Issa A, Khdair A, Bustanji Y. Inhibition of pancreatic lipase by berberine and dihydroberberine: an
  • investigation by docking simulation and experimental validation. Med Chem Res. 2013;22:2273-8. doi: 10.1007/s00044-012-0221-9.
  • Ilyas, Zahra et al. “The effect of Berberine on weight loss in order to prevent obesity: A systematic review.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 127 (2020): 110137. doi:10.1016/j.biopha.2020.110137
  • Xu, Xinmei et al. “Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 133 (2021): 110984.doi:10.1016/j.biopha.2020.110984


  • Costa MS, Toscano LT, Toscano LLT, Luna VR, Torres RA, Silva JA, Silva AS. Ergogenic potential of foods for performance and recovery: a new alternative in sports supplementation? A systematic review. Crit Rev Food Sci Nutr. 2022;62(6):1480-1501. doi: 10.1080/10408398.2020.1844137. Epub 2020 Nov 23. PMID: 33226268.
  • Jung EY, Kang DH, Suh HJ, Chang UJ. Effects of yeast hydrolysate on neuropeptide Y (NPY) and tryptophan hydroxylase (TPH) immunoreactivity in rats. Phytother Res. 2009 May;23(5):619-23. doi: 10.1002/ptr.2668. PMID: 19107837.
  • Jung EY, Cho MK, Hong YH, Kim JH, Park Y, Chang UJ, Suh HJ. Yeast hydrolysate can reduce body weight and abdominal fat accumulation in obese adults. Nutrition. 2014 Jan;30(1):25-32. doi: 10.1016/j.nut.2013.02.009. PMID: 24290594.
  • Jung EY, Lee JW, Hong YH, Chang UJ, Suh HJ. Low Dose Yeast Hydrolysate in Treatment of Obesity and Weight Loss. Prev Nutr Food Sci. 2017 Mar;22(1):45-49. doi: 10.3746/pnf.2017.22.1.45. Epub 2017 Mar 31. PMID: 28401087; PMCID: PMC5383141.


  • Park, Soo-Hyun et al. “Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo- controlled trial.” Obesity (Silver Spring, Md.) vol. 22,1 (2014): 63-71. doi:10.1002/oby.20539


  • Shen YC, Huang SC, Lin CP, et al. Anti-hyperglycemic and anti-hyperlipidemic activities of Radix Astragali and Panax notoginseng extract in human participants: A randomized, double-blind, crossover clinical trial. J Biochem Biotech 2022;5(3):111
  • Wang, Chun-Wen et al. “An Essential Role of cAMP Response Element Binding Protein in Ginsenoside Rg1-Mediated Inhibition of Na+/Glucose Cotransporter 1 Gene Expression.” Molecular pharmacology vol. 88,6 (2015): 1072-83. doi:10.1124/mol.114.097352
  • Huang, Yu-Chuan et al. “Effect and mechanism of ginsenosides CK and Rg1 on stimulation of glucose uptake in 3T3-L1 adipocytes.” Journal of agricultural and food chemistry vol. 58,10 (2010): 6039-47. doi:10.1021/jf9034755
  • Kim, Sung Jip et al. “Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells.” Biological & pharmaceutical bulletin vol. 33,2 (2010): 325-8. doi:10.1248/bpb.33.325


  • Alam MA, Uddin R, Subhan N, Rahman MM, Jain P, Reza HM. Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J Lipids. 2015;2015:496169. doi: 10.1155/2015/496169. Epub 2015 Jan 12. PMID: 25650336; PMCID: PMC4306384.
  • Yu, Yongmei et al. “Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice.” Scientific reports vol. 3 3142. 5 Nov. 2013, doi:10.1038/srep03142
  • Kaess, Bernhard M et al. “FGF21 signalling pathway and metabolic traits - genetic association analysis.” European journal of human genetics : EJHG vol. 18,12 (2010): 1344-8. doi:10.1038/ejhg.2010.130
  • Salminen, Antero et al. “Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.” Ageing research reviews vol. 37 (2017): 79-93. doi:10.1016/j.arr.2017.05.004